Microbix Biosystems Inc. develops and commercializes quality assessment products (QAPs™) formulated exclusively on Copan’s FLOQSwab®.

The respiratory viral QAPs™ product line is specifically designed to support point-of-care and central laboratory testing for common viruses, including SARS-CoV-2, Influenza, and Respiratory Syncytial Virus, among others. The formulations contain inactivated whole genome or native viruses desiccated on clinically relevant swab types in order to simulate patient specimens.

The FLOQ co-branded swab products (REDx™FLOQ® and PROCEEDx™FLOQ®) are stored at room temperature, are cross-platform compatible by design, and can be eluted in your choice of media.